Obesity and reproduction: an educational bulletin

Fertility and Sterility

Volumn 90, Issue 5 SUPPL., 2008, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRA EXTRACT; FENFLURAMINE; GONADOTROPIN; METFORMIN; PHENTERMINE RESIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CONSTIPATION; DEPRESSION; DRUG COST; DRUG EFFECT; FATIGUE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; INSOMNIA; INTRACRANIAL HYPERTENSION; LACTIC ACIDOSIS; LIFESTYLE MODIFICATION; MALE FERTILITY; MENSTRUAL IRREGULARITY; NUTRITIONAL ASSESSMENT; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP DISORDER; XEROSTOMIA;

ABORTION, SPONTANEOUS; FEMALE; HUMANS; INFERTILITY, FEMALE; MALE; MENSTRUAL CYCLE; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REPRODUCTION; RISK FACTORS;

EID: 55449131907     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.005     Document Type: Article

References (95)

1. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among U.S. children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
2. Castillo-Martinez L., Lopez-Alvarenga J.C., Villa A.R., and Gonzalez-Barranco J. Menstrual cycle length disorders in 18-to 40-y-old obese women. Nutrition 19 (2003) 317-320
3. Douchi T., Kuwahata R., Yamamoto S., Oki T., Yamasaki H., and Nagata Y. Relationship of upper body obesity to menstrual disorders. Acta Obstet Gynecol Scand 81 (2002) 147-150
4. Hartz A.J., Rupley D.C., and Rimm A.A. The association of girth measurements with disease in 32,856 women. Am J Epidemiol 119 (1984) 71-80
5. Pasquali R., Pelusi C., Genghini S., Cacciari M., and Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 9 (2003) 359-372
6. Lake J.K., Power C., and Cole T.J. Women's reproductive health: the role of body mass index in early and adult life. Int J Obes Relat Metab Disord 21 (1997) 432-438
7. Howe G., Westhoff C., Vessey M., and Yeates D. Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study. Br Med J (Clin Res Ed) 290 (1985) 1697-1700
8. Rich-Edwards J.W., Goldman M.B., Willett W.C., Hunter D.J., Stampfer M.J., Colditz G.A., et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 171 (1994) 171-177
9. Clark A.M., Ledger W., Galletly C., Tomlinson L., Blaney F., Wang X., et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10 (1995) 2705-2712
10. Zaadstra B.M., Seidell J.C., Van Noord P.A., te Velde E.R., Habbema J.D., Vrieswijk B., et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ 306 (1993) 484-487
11. Jensen M.D. Medical management of obesity. Semin Gastrointest Dis 9 (1998) 156-162
12. Bolumar F., Olsen J., Rebagliato M., Saez-Lloret I., and Bisanti L. Body mass index and delay conception: a European multicenter study on infertility and subfecundity. Am J Epidemiol 151 (2000) 1072-1079
13. Gesink Law D.C., Maclehose R.F., and Longnecker M.P. Obesity and time to pregnancy. Hum Reprod 22 (2007) 414-420
14. van der Steeg J.W., Steures P., Eijkemans M.J., Habbema J.D., Hompes P.G., Burggraaff J.M., et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod 23 (2008) 324-328
15. Fedorcsák P., Dale P.O., Storeng R., Ertzeid G., Bjercke S., Oldereid N., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 19 (2004) 2523-2528
16. Wang J.X., Davies M., and Norman R.J. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 321 (2000) 1320-1321
17. Dokras A., Baredziak L., Blaine J., Syrop C., VanVoorhis B.J., and Sparks A. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol 108 (2006) 61-69
18. Wang J.X., Davies M.J., and Norman R.J. Obesity increases the risk of spontaneous abortion during infertility treatment. Obesity Res 10 (2002) 551-554
19. Weiss J.L., Malone F.D., Emig D., Ball R.H., Nyberg D.A., Comstock C.H., et al. FASTER Research Consortium. Obesity, obstetric complications and cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol 190 (2004) 1091-1097
20. Cedergren M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 103 (2004) 219-224
21. Watkins M.L., Rasmussen S.A., Honein M.A., Botto L.D., and Moore C.A. Maternal obesity and risk of birth defects. Pediatrics 111 (2003) 1152-1158
22. Gluckman P.D., Hanson M.A., and Pinal C. The developmental origins of adult disease. Matern Child Nutr 1 (2005) 130-141
23. Balen A.H., and Rutherford A.J. Managing anovulatory infertility and polycystic ovary syndrome. BMJ 335 (2007) 663-666
24. Nelson S.M., and Fleming R. Obesity and reproduction: impact and interventions. Curr Opin Obstet Gynecol 19 (2007) 384-389
25. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
26. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 (1997) 774-800
27. Pasquali R., Casimirri F., Cantobelli S., Labate A.M., Venturoli S., Paradisi R., et al. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res 39 (1993) 179-187
28. Agarwal S.K., Vogel K., Weitsman S.R., and Magoffin D.A. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 84 (1999) 1072-1076
29. Duggal P.S., Van Der Hoek K.H., Milner C.R., Ryan N.K., Armstrong D.T., Magoffin D.A., et al. The in vivo and in vitro effects of exogenous leptin on ovulation in the rat. Endocrinology 141 (2000) 1971-1976
30. Sallmén M., Sandler D.P., Hoppin J.A., Blair A., and Baird D.D. Reduced fertility among overweight and obese men. Epidemiology 17 (2006) 520-523
31. Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril 85 (2006) 1319-1340
32. Ramlau-Hansen C.H., Thulstrup A.M., Nohr E.A., Bonde J.P., Sørensen T.I., and Olsen J. Subfecundity in overweight and obese couples. Hum Reprod 22 (2007) 1634-1637
33. Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW. Male obesity and alteration in sperm parameters. Fertil Steril. Published online January 4, 2008 [E-pub ahead of print].
34. Jarow J.P., Kirkland J., Koritnik D.R., and Cefalu W.T. Effect of obesity and fertility status on sex steroid levels in men. Urology 42 (1993) 171-174
35. Bray G.A. Obesity and reproduction. Hum Reprod 12 Suppl 1 (1997) 26-32
36. Baker H.W. Reproductive effects of nontesticular illness. Endocrinol Metab Clin North Am 27 (1998) 831-850
37. Jung A., and Schill W.B. Male infertility. Current life style could be responsible for infertility. MMW Fortschr Med 142 (2000) 31-33
38. Mulcahy J.J. Scrotal hypothermia and the infertile man. J Urol 132 (1984) 469-470
39. Mounzih K., Lu R., and Chehab F.F. Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology 138 (1997) 1190-1193
40. Manson J.E., Willett W.C., Stampfer M.J., Colditz G.A., Hunter D.J., Hankinson S.E., et al. Body weight and mortality among women. N Engl J Med 333 (1995) 677-685
41. Rexrode K.M., Carey V.J., Hennekens C.H., Walters E.E., Colditz G.A., Stampfer M.J., et al. Abdominal adiposity and coronary heart disease in women. JAMA 280 (1998) 1843-1848
42. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345 (2001) 790-797
43. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk of type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
44. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., and Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1999) 141-146
45. Calle E.E., and Thun M.J. Obesity and cancer. Oncogene 23 (2004) 6365-6378
46. Friedman D.I. Pseudotumor cerebri. Neurosurg Clin North Am 10 (1999) 609-621
47. Johnston E., Johnson S., McLeod P., and Johnston M. The relation of body mass index to depressive symptoms. Can J Public Health 95 (2004) 179-183
48. Dong C., Sanchez L.E., and Price R.A. Relationship of obesity to depression: a family-based study. Int J Obes Relat Metab Disord 28 (2004) 790-795
49. Williamson D.F., Pamuk E., Thun M., Flanders D., Byers T., and Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 141 (1995) 1128-1141
50. Moran L.J., Noakes M., Clifton P.M., Tomlinson L., Galletly C., and Norman R.J. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 812-819
51. Kiddy D.S., Hamilton-Fairley D., Bush A., Short F., Anyaoku V., Reed M.J., et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 36 (1992) 105-111
52. Crosignani P.G., Colombo M., Vegetti W., Somigliana E., Gessati A., and Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18 (2003) 1928-1932
53. Holte J., Bergh T., Berne C., Wide L., and Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80 (1995) 2586-2593
54. Pate R.R., Pratt M., Blair S.N., Haskell W.L., Macera C.A., Bouchard C., et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273 (1995) 402-407
55. Wadden T.A., and Foster G.D. Behavioral treatment of obesity. Med Clin North Am 84 (2000) 441-461
56. Clark A.M., Thornley B., Tomlinson L., Galletley C., and Norman R.J. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 13 (1998) 1502-1505
57. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 6 Suppl 2 (1998) 51S-209S
58. Foster G.D., Wyatt H.R., Hill J.O., McGuckin B.G., Brill C., Mohammed B.S., et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348 (2003) 2082-2090
59. Dansinger M.L., Gleason J.A., Griffith J.L., Selker H.P., and Schaefer E.J. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 293 (2005) 43-53
60. Bray G.A. Uses and misuses of the new pharmacotherapy of obesity. Ann Med 31 (1999) 1-3
61. Yanovski S.Z., and Yanovski J.A. Obesity. N Engl J Med 346 (2002) 591-602
62. Serdula M.K., Khan L.K., and Dietz W.H. Weight loss counseling revisited. JAMA 289 (2003) 1747-1750
63. Haddock C.K., Poston W.S., Dill P.L., Foreyt J.P., and Ericsson M. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord 26 (2002) 262-273
64. Wadden T.A., Berkowitz R.I., Womble L.G., Sarwer D.B., Phelan S., Cato R.K., et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 353 (2005) 2111-2120
65. Connolly H.M., Crary J.L., McGoon M.D., Hensrud D.D., Edwards B.S., Edwards W.D., et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337 (1997) 581-588
66. Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X., et al., International Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 335 (1996) 609-616
67. Keating G.M., and Jarvis B. Orlistat: in the prevention and treatment of type 2 diabetes mellitus. Drugs 61 (2001) 2107-2119
68. Glazer G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Arch Intern Med 161 (2001) 1814-1824
69. Lord J.M., Flight I.H., and Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327 (2003) 951-953
70. Fleming R., Hopkinson Z.E., Wallace A.M., Greer I.A., and Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 87 (2002) 569-574
71. Tang T., Glanville J., Hayden C.J., White D., Barth J.H., and Balen A.H. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 21 (2006) 80-89
72. Pasquali R., Gambineri A., Biscotti D., Vicennati V., Gagliardi L., Colitta D., et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85 (2000) 2767-2774
73. Crave J.C., Fimbel S., Lejeune H., Cugnardey N., Dechaud H., and Pugeat M. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80 (1995) 2057-2062
74. Harborne L., Fleming R., Lyall H., Norman J., and Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet 361 (2003) 1894-1901
75. Azziz R., Ehrmann D., Legro R.S., Whitcomb R.W., Hanley R., Fereshetian A.N., et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86 (2001) 1626-1632
76. Asnani S., Richard B.C., Desouza C., and Fonseca V. Is weight loss possible in patients treated with thiazolidinediones? Experience with a low-calorie diet. Curr Med Res Opin 19 (2003) 609-613
77. Practice Committee of the American Society for Reproductive Medicine. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome. Fertil Steril 90 (2008) S69-S73
78. Samenuk D. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 77 (2002) 12-16
79. Van Gaal L.F., Rissanen A.M., Scheen A.J., Ziegler O., Rössner S., and RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365 (2005) 1389-1397
80. Després J.P., Golay A., Sjöström L., and Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353 (2005) 2121-2134
81. Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., Rosenstock J., and RIO-North America Study Group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295 (2006) 761-775 Erratum: JAMA 2006;295:1252
82. Van Gaal L., Pi-Sunyer X., Després J.P., McCarthy C., and Scheen A. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care 31 Suppl 2 (2008) S229-S240
83. Christensen R., Kristensen P.K., Bartels E.M., Bliddal H., and Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370 (2007) 1706-1713 Erratum: Lancet 2008;371:558
84. Trus T.L., Pope G.D., and Finlayson S.R. National trends in utilization and outcomes of bariatric surgery. Surg Endosc 19 (2005) 616-620
85. Buchwald H., and Williams S.E. Bariatric surgery worldwide 2003. Obes Surg 14 (2004) 1157-1164
86. Genco A., Cipriano M., Bacci V., Cuzzolaro M., Materia A., Raparelli L., et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond) 30 (2006) 129-133
87. Consensus Development Conference Panel, NIH Conference. Gastrointestinal surgery for severe obesity. Ann Intern Med 115 (1991) 956-961
88. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery. A systematic review and meta-analysis. JAMA 292 (2004) 1724-1737 Erratum: JAMA 2005;293:1728
89. Maggard M.A., Shugarman L.R., Suttorp M., Maglione M., Sugarman H.J., Livingston E.H., et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 142 (2005) 547-559
90. Deitel M., Stone E., Kassam H.A., Wilk E.J., and Sutherland D.J. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr 7 (1988) 147-153
91. di Frega A.S., Dale B., Di Matteo L., and Wilding M. Secondary male factor infertility after Roux-en-Y gastric bypass for morbid obesity: case report. Hum Reprod 20 (2005) 997-998
92. Sheiner E., Levy A., Silverberg D., Menes T.S., Levy I., Katz M., et al. Pregnancy after bariatric surgery is not associated with adverse perinatal outcome. Am J Obstet Gynecol 190 (2004) 1335-1340
93. Printen K.J., and Scott D. Pregnancy following gastric bypass for the treatment of morbid obesity. Am Surg 48 (1982) 363-365
94. Marceau P., Kaufman D., Biron S., Hould F.S., Lebel S., Marceau S., et al. Outcome of pregnancies after biliopancreatic diversion. Obes Surg 14 (2004) 318-324
95. Moore K.A., Ouyang D.W., and Whang E.E. Maternal and fetal deaths after gastric bypass surgery for morbid obesity. N Engl J Med 351 (2004) 721-722